Novel Field-Assisted LOAC System – A New Era in Rapid Point-of-Care Diagnostics
Company Founder, Chairman and CEO, Professor
The EFADchip technology uses electric field-assisted DNA hybridization to accelerate the detection of biological samples on a single chip. The key differentiator of this technology is the use of a dielectric material for both electric field generation and capture probe DNA immobilization, thus avoiding adverse electrochemical effects that can lead to reduced sensitivity and accuracy of detection. The EFADchip is fabricated using widely available materials and common photolithographic techniques well known in the miniaturized electronics industry, resulting in a structure that is inherently stable under varying ambient conditions.
This platform has the potential to revolutionize clinical diagnostics practices, by providing a cost-effective solution for point-of-care applications and the potential for individualized medicine. HKLife’s EFADchip:
-- Uses novel technology to accelerate the migration of DNA to the reactive sites within the chip, thereby enabling rapid, sensitive and specific hybridization in minutes without the undesirable impact of electrochemical reactions, -- Employs a signal detection system that does not require fluorescence, having a substantial impact on the present cost parameters where complexity of detection equipment is a significant deterrent for wide-spread adoption, -- Has the potential to be customized for specific market applications including the full spectrum of molecular diagnostics, drug discovery, bio-security and forensics, -- Is not limited to human application and is suitable for a variety of veterinary, food safety and environmental needs, either in remote areas or the industrial setting, and -- Will provide an easy-to-use, portable and low-cost detection solution, enabling rapid throughput screening for simple or multiple dangerous diseases, a precursor to a bio-radar surveillance system.
Prof Yu’s introduction of the EFADchip technology was extremely well received by the molecular medicine industry audience at the Tri-Conference. His presentation gave them food-for-thought and initiated discussions around the concepts of diagnostic tools and bio-radar surveillance. Clearly, HKLife’s focus on revolutionizing point-of-care diagnostics and realizing personalized medicine was of timely and significant interest to them. This is the first in a series of communications that HKLife has planned throughout 2009. They will be announcing further evolutionary steps and sharing more detailed performance-based results from their exciting new technology.
Hai Kang Life Corporation Limited, formerly known as Hong Kong DNA Chips, was established with independent research funding in 1999. The company is strategically positioned at the hub of Asian biotechnology, equipped with the most advanced research and production facilities in both
For more information about HKLife’s EFADchip, visit http://www.haikanglife.com
Contact: firstname.lastname@example.org Kinnie Ho in Hong Kong +852 2111 2123 ext 30 Eric Cox in Beijing +86 10 58022828 ext 304
SOURCE Frost & Sullivan